Abbisko
Abbisko is a biopharmaceutical company that develops and commercializes medicines for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 1-10
Industries / Tags:
Detailed Abbisko Information
Geographic Data
Address: No. 898, Halei Road
City: Shanghai
State: shanghai municipality
Zip: 20120
Country: CN
Financial Info
Stage:
series d
Raised Last:
$123M
Raised Total:$263M
Social
Metrics
3,651,395Website Global Rank
3,875Website Monthly Traffic
Twitter Followers
Description
Abbisko is a biopharmaceutical company that develops and commercializes medicines for the treatment of cancer.
Contact Phone:
Contact Email:
Abbisko went public on 10/15/2021 on the Hong Kong Stock Exchange
Listed Exchange:
Hong Kong Stock Exchange
IPO Date:
10/15/2021
IPO Valuation:
$1B
Ticker Symbol:
2256
IPO Price:
$1.6019439319623814/share
Amount Raised:
$226M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
